US 10420751
Methods of treating inflammatory bowel disease with AMD3100 and tacrolimus
granted A61KA61K31/00A61K31/365
Quick answer
US patent 10420751 (Methods of treating inflammatory bowel disease with AMD3100 and tacrolimus) held by MedRegen, LLC expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MedRegen, LLC
- Grant date
- Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/00, A61K31/365, A61K31/395, A61K31/436